1. Derhaschnig U, Jilma B (2010) Phase-I studies and first-in-human trials. In: Müller M (ed) Clinical pharmacology: current topics and case studies. Springer, Vienna, pp 89–99
2. Dixon JR (1999) The international conference on harmonization good clinical practice guideline. Qual Assur 6(2):65–74
3. Dunnington K, Benrimoh N, Brandquist C, Cardillo-Marricco N, Di Spirito M, Grenier J (2018) Application of pharmacokinetics in early drug development. In: Pharmacokinetics and adverse effects of drugs-mechanisms and risks factors. IntechOpen
4. European Commission (2003) Commission Directive 2003/94/EC laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:262:0022:0026:en:PDF. Accessed 16 April 2020
5. European Commission (n.d.) European Union Drug Regulating Authorities Clinical Trials Database. https://eudract.ema.europa.eu/. Accessed 6 April 2020